Active Ingredient: CISATRACURIUM BESYLATE
Proprietary Name: CISATRACURIUM BESYLATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 2MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A203079
Product Number: 001
Approval Date: Apr 19, 2023
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
